人工血管の市場規模、シェア、成長分析、原材料別、適応症別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

人工血管の世界市場規模は、2022年に約15億米ドルと評価され、予測期間（2024-2031年）のCAGRは7.2%で、2023年の16億米ドルから上昇し、2031年には28億米ドルに達すると予測されています。

世界の人工血管市場は、心血管疾患の有病率の上昇、医療技術の進歩、世界人口の高齢化などを背景に大きな成長を遂げています。糖尿病、高血圧、肥満の増加は血管障害の増加に寄与しており、人工血管の需要をエスカレートさせています。合成移植片や生体工学移植片などの技術革新が血管手術の成功率を向上させ、市場をさらに押し上げています。また、低侵襲手術手技の使用も、回復時間の短縮や合併症の減少につながっています。さらに、末期腎疾患の増加により、透析アクセス手術に使用される人工血管の需要が高まっています。新興市場における医療費の増加や、医療インフラの改善を目的とした政府の取り組みも、市場の拡大に寄与しています。しかし、人工血管、特に高度なバイオエンジニアリング・タイプの高額なコストや、血栓症や感染症などの合併症のリスクといった課題が、市場の成長を制限しています。地理的には、北米が人工血管市場を独占しているが、これは高度なヘルスケア・インフラ、高額な医療費、血管疾患を患う患者人口の多さによるものです。しかし、アジア太平洋地域は、ヘルスケア投資の増加、意識の高まり、医療インフラの改善により、最も速い成長が見込まれています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• 規制分析
• 特許分析
• 原材料の分析

人工血管市場：原材料別

• 市場概要
• ポリエステルグラフト
• エプトフェグラフト
• ポリウレタングラフト
• 生合成移植

人工血管市場：適応症別

• 市場概要
• 血管内動脈瘤修復
  • 腹部大動脈瘤の修復
  • 胸部大動脈瘤の修復
• 末梢血管修復
• 血液透析アクセス

人工血管市場：エンドユーザー別

• 市場概要
• 病院
• 外来手術センター

人工血管市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Medtronic
• Terumo
• C. R. Bard
• B. Braun Melsungen AG
• Cardinal Health
• Endologix
• Lemaitre Vascular
• Cook Medical
• Maquet
• Gore Medical

Global Vascular Grafts Market size was valued at around 1.5 billion in 2022 and is expected to rise from USD 1.6 billion in 2023 to reach a value of USD 2.8 billion by 2031, at a CAGR of 7.2% over the forecast period (2024-2031).

The Global Vascular Grafts Market is experiencing significant growth, driven by the rising prevalence of cardiovascular diseases, advancements in medical technology, and an aging global population. The increasing cases of diabetes, hypertension, and obesity have contributed to a rise in vascular disorders, which has, in turn, escalated the demand for vascular grafts. Technological innovations such as synthetic and bio-engineered grafts are improving the success rates of vascular surgeries, further boosting the market. The use of minimally invasive surgical techniques is also gaining traction, leading to quicker recovery times and fewer complications. Moreover, an increase in end-stage renal diseases has led to a higher demand for vascular grafts used in dialysis access surgeries. The rise in healthcare expenditure in emerging markets, alongside government initiatives aimed at improving healthcare infrastructure, is also contributing to market expansion. However, challenges such as high costs of vascular grafts, especially advanced and bio-engineered types, and risks of complications such as thrombosis and infection are limiting market growth. Geographically, North America dominates the vascular grafts market due to its advanced healthcare infrastructure, high healthcare expenditure, and a large patient population suffering from vascular diseases. However, the Asia-Pacific region is expected to witness the fastest growth due to increasing healthcare investments, growing awareness, and improving medical infrastructure.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vascular Grafts Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vascular Grafts Market Segmental Analysis

Global Vascular Grafts Market is segmented by Raw Material, Indication, End User, and region. Based on Raw Material, the market is segmented into Polyester Grafts, ePTFE, Polyurethane Grafts, and Biosynthetic Grafts. Based on Indication, the market is segmented into Endovascular Aneurysm Repair, Abdominal Aortic Aneurysms Repair, Thoracic Aortic Aneurysm Repair, Peripheral Vascular, and Hemodialysis Access. Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Vascular Grafts Market

One of the primary drivers of the vascular grafts market is the alarming rise in cardiovascular diseases (CVDs) globally. Sedentary lifestyles, poor dietary habits, and increasing smoking and alcohol consumption have contributed to a higher prevalence of CVDs, including coronary artery disease, aneurysms, and peripheral arterial disease. As CVDs often result in blocked or weakened arteries, vascular grafts become essential to restoring blood flow and preventing severe complications like heart attacks or strokes. The aging population also contributes to this trend, as older adults are more susceptible to vascular diseases. For instance, the World Health Organization (WHO) estimates that cardiovascular diseases account for around 32% of global deaths, emphasizing the need for timely surgical intervention. This rising burden of cardiovascular diseases is driving the demand for vascular grafts, as they play a critical role in bypass surgeries, vascular repairs, and hemodialysis access for patients with end-stage renal disease, further fueling market growth.

Restraints in the Global Vascular Grafts Market

One of the major restraints in the vascular grafts market is the high cost associated with advanced graft materials and surgical procedures. Synthetic and bio-engineered grafts, while offering better outcomes in terms of biocompatibility and longevity, tend to be significantly more expensive than traditional graft materials. The production processes for these advanced grafts involve complex biotechnology and require stringent quality control, leading to higher costs. This financial barrier can be particularly challenging in low- and middle-income countries, where healthcare budgets are limited, and patients may struggle to afford these treatments. Additionally, insurance coverage for vascular graft surgeries may not always be comprehensive, further limiting access to advanced treatments. The high cost can also deter healthcare providers from adopting newer technologies, preferring more traditional, affordable options, despite the clinical benefits offered by cutting-edge vascular graft solutions. This price sensitivity acts as a constraint, slowing the widespread adoption of advanced vascular grafts, especially in resource-limited settings.

Market Trends of the Global Vascular Grafts Market

A notable trend in the vascular grafts market is the growing shift towards bioengineered and biodegradable grafts, driven by the increasing need for biocompatible and long-lasting solutions. Traditional synthetic grafts, such as those made from PTFE (polytetrafluoroethylene) or Dacron, are effective but pose risks of infection, rejection, or thrombosis over time. In response, researchers and manufacturers are focusing on developing grafts that can better integrate with the body's tissues, promoting natural healing and reducing complications. Bioengineered grafts, often made from collagen, elastin, or decellularized tissues, mimic the natural properties of blood vessels, improving their compatibility and performance in vascular surgeries. Biodegradable grafts, on the other hand, are designed to degrade over time, allowing the body's own tissues to regenerate and take over the graft's function. This trend towards more natural, tissue-friendly materials is expected to reduce the risk of long-term complications and improve patient outcomes, making it a key area of focus for future advancements in the vascular grafts market.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Analysis
• Patent Analysis
• Raw Material Analysis

Vascular Graft Market, By Raw Material

• Market Overview
• Polyester Grafts
• Eptfe Grafts
• Polyurethane Grafts
• Biosynthetic Grafts

Vascular Graft Market, By Indication

• Market Overview
• Endovascular Aneurysm Repair
  • Abdominal Aortic Aneurysms Repair
  • Thoracic Aortic Aneurysm Repair
• Peripheral Vascular Repair
• Hemodialysis Access

Vascular Graft Market, By End User

• Market Overview
• Hospitals
• Ambulatory Surgical Centers

Vascular Graft Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C. R. Bard
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lemaitre Vascular
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Maquet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gore Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments